218 related articles for article (PubMed ID: 25467002)
1. Clinical validation of FDG-PET/CT in the radiation treatment planning for patients with oesophageal cancer.
Muijs CT; Beukema JC; Woutersen D; Mul VE; Berveling MJ; Pruim J; van der Jagt EJ; Hospers GA; Groen H; Plukker JT; Langendijk JA
Radiother Oncol; 2014 Nov; 113(2):188-92. PubMed ID: 25467002
[TBL] [Abstract][Full Text] [Related]
2. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer.
Leong T; Everitt C; Yuen K; Condron S; Hui A; Ngan SY; Pitman A; Lau EW; MacManus M; Binns D; Ackerly T; Hicks RJ
Radiother Oncol; 2006 Mar; 78(3):254-61. PubMed ID: 16545881
[TBL] [Abstract][Full Text] [Related]
3. Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability: PET/CT improves esophageal target definition.
Schreurs LM; Busz DM; Paardekooper GM; Beukema JC; Jager PL; Van der Jagt EJ; van Dam GM; Groen H; Plukker JT; Langendijk JA
Dis Esophagus; 2010 Aug; 23(6):493-501. PubMed ID: 20113320
[TBL] [Abstract][Full Text] [Related]
4. Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma.
Zheng XK; Chen LH; Wang QS; Wu HB; Wang HM; Chen YQ; Yan WP; Li QS; Xu YK
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1381-8. PubMed ID: 17869450
[TBL] [Abstract][Full Text] [Related]
5. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.
Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Houry S; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):340-5. PubMed ID: 16168829
[TBL] [Abstract][Full Text] [Related]
6. Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies.
Geets X; Daisne JF; Tomsej M; Duprez T; Lonneux M; Grégoire V
Radiother Oncol; 2006 Mar; 78(3):291-7. PubMed ID: 16499982
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy doses.
Nkhali L; Thureau S; Edet-Sanson A; Doyeux K; Benyoucef A; Gardin I; Michel P; Vera P; Dubray B
Acta Oncol; 2015 Jun; 54(6):909-15. PubMed ID: 25417733
[TBL] [Abstract][Full Text] [Related]
8. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of ¹⁸FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies.
Terezakis SA; Schöder H; Kowalski A; McCann P; Lim R; Turlakov A; Gonen M; Barker C; Goenka A; Lovie S; Yahalom J
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):376-83. PubMed ID: 24726287
[TBL] [Abstract][Full Text] [Related]
10. Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy.
Leclerc M; Lartigau E; Lacornerie T; Daisne JF; Kramar A; Grégoire V
Radiother Oncol; 2015 Jul; 116(1):87-93. PubMed ID: 26088157
[TBL] [Abstract][Full Text] [Related]
11. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
12. Radiation field design and patterns of locoregional recurrence following definitive radiotherapy for breast cancer.
Chen SA; Schuster DM; Mister D; Liu T; Godette K; Torres MA
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):309-14. PubMed ID: 23312271
[TBL] [Abstract][Full Text] [Related]
13. Defining the target in cancer of the oesophagus: direct radiotherapy planning with fluorodeoxyglucose positron emission tomography-computed tomography.
le Grange F; Wickers S; Warry A; Warrilow J; Bomanji J; Tobias JS
Clin Oncol (R Coll Radiol); 2015 Mar; 27(3):160-7. PubMed ID: 25540907
[TBL] [Abstract][Full Text] [Related]
14. [Impact of computed tomography (CT) and 18F-deoxyglucose positron emission tomography (FDG-PET) image fusion for conformal radiotherapy in esophageal carcinoma].
Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petenief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Hourry S; Talbot JN
Cancer Radiother; 2005 May; 9(3):152-60. PubMed ID: 16023043
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer.
Bassi MC; Turri L; Sacchetti G; Loi G; Cannillo B; La Mattina P; Brambilla M; Inglese E; Krengli M
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1423-6. PubMed ID: 17931795
[TBL] [Abstract][Full Text] [Related]
16. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
[TBL] [Abstract][Full Text] [Related]
17. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.
Gondi V; Bradley K; Mehta M; Howard A; Khuntia D; Ritter M; Tomé W
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):187-95. PubMed ID: 17189070
[TBL] [Abstract][Full Text] [Related]
18. [Radiotherapy volume delineation based on (
Encaoua J; Abgral R; Leleu C; El Kabbaj O; Caradec P; Bourhis D; Pradier O; Schick U
Cancer Radiother; 2017 Jun; 21(4):267-275. PubMed ID: 28499658
[TBL] [Abstract][Full Text] [Related]
19. Automated biological target volume delineation for radiotherapy treatment planning using FDG-PET/CT.
Niyazi M; Landrock S; Elsner A; Manapov F; Hacker M; Belka C; Ganswindt U
Radiat Oncol; 2013 Jul; 8():180. PubMed ID: 23848981
[TBL] [Abstract][Full Text] [Related]
20. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study.
Brændengen M; Hansson K; Radu C; Siegbahn A; Jacobsson H; Glimelius B
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e439-45. PubMed ID: 21641122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
